Assessing Attitudes Towards Medicinal Cannabis and Cannabinoid Use Among Dementia Patients and Their Caregivers

The results from this questionnaire show that there is a strong interest from Australian dementia patients and their caregivers to participate in future clinical trials that would assess the effectiveness of medicinal cannabis in alleviating dementia symptoms. As evidenced by this and other studies, there is growing support for the consideration of cannabis-derived products as medical treatments. We propose that robustly designed clinical trials with clearly defined outcome measures would be of interest and have the potential to expand symptomatic treatment options to those living with dementia.